LH 2021

General Information


The role of luteinizing hormone (LH) during folliculogenesis has intrigued the scientific and medical community for at least three decades. There is an emerging galaxy of research to explore concerning this enigmatic subject. The availability of recombinant drugs now offers, for the first time, the opportunity to examine the role of follicle stimulating hormone and LH separately. An emerging topic during last year’s conference was LH supplementation to improve the outcome in a subgroup of low prognosis patients selected according to POSEIDON classification.

This new virtual preceptorship is designed to explore the role of luteinizing activity during folliculogenesis and beyond. The virtual preceptorship will feature and summarise educational material released during the last edition of the Virtual World Conference on Luteinizing Hormone in ART. In addition, three live sessions (practical session in three ‘host’ clinics) will be streamed live and each session will provide the opportunity for more practical in-depth learning. Each live session will engage a group of participants that has prepared case studies and questions. The chairs will present selected case studies/questions focusing on LH and ART, and discuss them live together with the host Clinic team. Prior to each live session, relevant MCQ and literature will be shared with participants. The pre-live exercises will guide discussion on the optimal clinical management for each case.

During the preceptorship, the participant can also visit the chat room to discuss interesting topics and debate with colleagues. The virtual preceptorship doesn’t stop there – A library with a collection of recent articles related to the program will be freely available to all participants. We hope you find this learning experience, on the role of luteinizing hormone in ART, to benefit your on-going education. We look forward to welcoming you to this next exploration.

Learning Objectives

  • Understand the importance of luteinizing activity during folliculogenesis and beyond.
  • Understand the dynamics of hypothalamic-pituitary axis in the pathogenesis of hypo- and normo-gonadotropic amenorrhea.
  • Comprehend the concept of relative gonadotropin deficiency.
  • Discuss and debate the management of low prognosis patients.
  • Comprehend the clinical utility of the POSEIDON classification for the management of low prognosis women.
  • Discover the clinical relevance of LH supplementation in ART.
  • Appreciate the clinical relevance and pathogenesis of the progesterone rise during COS.
  • Analyse the relevance of LH during the luteal phase and Introduce the concept of individualized luteal phase support.
  • Explore the potential of LH in male infertility.

Target Audience

The programme is intended for clinicians, embryologists, andrologists, scientists, and managers working in ART who wish to update their knowledge of advanced techniques and scientific innovations and understand best practices using evidence-based models of care.


The live sessions will be submitted for CME accreditation to EACCME® (European Accreditation Council for Continuing for Medical Education).



Carlo Alviggi

Naples, Italy


Sandro C. Esteves

Campinas, Brazil


Robert Fischer

Hamburg, Germany


Peter Humaidan

Aarhus University

General Information

First Scientific Annoucement

Main Topics

  • Gonadotropins during ovarian cycles: the galaxy we know
  • Hypothalamic amenorrhea and PCOS: two sides of the moon
  • The role of LH in male infertility: an altered connection between space and earth
  • Isoforms and polymorphisms of gonadotropins and their receptors in human reproduction: a partial eclipse
  • The periodic comet of POR: the novel POSEIDON classification
  • Orbiting around clinical practice: management of the four POSEIDON groups
  • Progesterone rise: the black hole of controlled ovarian stimulation
  • Ongoing pregnancy rate as a valid endpoint: mapping a new star system
  • Antral follicle count: an “objective” dimension?
  • Follicular waves during the natural cycle: use of Duo-Stim in POSEIDON groups
  • Ovulation triggering: the big bang of an adequate luteal phase
  • Landing in Real World “Data”


The official language of the activity will be English.

Simultaneous translation (from/to English/Chinese/French/Spanish) will be provided.

CME Provider

Med.E.A – Medical Education Academy

Chloe Xilinas: Programme and Relations Manager in Medical Education


Registration starts on 2 July 2021.
Starting on that date, and until the online preceptorship takes off on 30 September 2021, you can register for free to the conference.

To pre-register now enter: www.lh2021.education

For registration information please contact:



Med.E.A Srl educational programmes are organized solely to promote the exchange and dissemination of scientific and medical information. No forms of promotional activities are permitted. There may be presentations discussing investigational uses of various products.

These views are the responsibility of the named speakers, and do not represent an endorsement or recommendation on the part of Med.E.A. Srl. This educational activity is supported by independent grants from the Healthcare business of Merck KGaA, Darmstadt, German; Fujifilm Europe B.V.